A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Draeger Safety UK Launches X-am 2800 – A New Mobile Gas Detector

DraegerSafety UK, a leader in the fields of safety and medical technology, has today launched a new mobile gas detector, the X-am 2800, to add to its extensive safety and gas detection portfolio.

Dräger, which has over 100 years’ expertise in gas detection, has developed the new device, which offers simultaneous measurement of up to four different gases, for application in confined spaces to safeguard employees working in areas at risk of oxygen depletion, explosive atmospheres, or those where toxic substances may be present.

With integrated Bluetooth connectivity, live gas readings and alerts can be transferred in real-time to Dräger’s Gas Detection Connect cloud solution. This provides users with secure access to critical data at any time, from anywhere, through an internet browser.

Adam Pope, Marketing Manager, Mobile Gas Measurement, Draeger Safety UK, comments: “The new X-am 2800 will provide customers with the combined benefit of the latest connected technology plus a range of new features which mean that the X-am 2800 is a highly reliable and robust product.”

Mobile gas detectors are worn on the body, so robustness is key to their functioning reliability and the X-am 2800 has been independently drop-tested to withstand a fall of more than two metres on concrete: a result of its resilient design.

Another key advantage of the X-am 2800 is its suitability to be used in wet environments and, as part of its development the X-am has been tested in line with International Protection Rating Class 68 which measures the resistance of a device against dust and water. This makes it particularly useful for both utilities and energy industries, and when combined with support and service offerings, the X-am provides a total mobile gas solution.

Furthermore, efficient fleet management is provided by the cloud-connected Dräger X-dock test station, which automates the process of detector testing and calibration. All data on testing, calibration and device event history can be automatically transferred to Gas Detection Connect and reported on, to ensure personnel equipment is consistent, reliable, and accurate.

Adam Pope adds: “Our research has indicated that the introduction of new technology, which includes the use of connectivity, provides considerable opportunity to improve safety in the workplace, through advances such as real-time monitoring using systems such as Dräger Gas Detection Connect to provide additional safeguards to employee safety.”

“The new X-am also supports businesses’ sustainability goals both directly in relation to its reduced packaging and durable long-life sensors, and indirectly through its compatibility with existing X-am accessories.”

For more information on the X-am 2800 visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy